Interferon regulatory factor 5 represses expression of the Epstein-Barr virus oncoprotein LMP1: braking of the IRF7/LMP1 regulatory circuit.
about
IRF7: activation, regulation, modification and functionThe A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7Oncogenic IRFs provide a survival advantage for Epstein-Barr virus- or human T-cell leukemia virus type 1-transformed cells through induction of BIC expressionInterferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1A gammaherpesvirus cooperates with interferon-alpha/beta-induced IRF2 to halt viral replication, control reactivation, and minimize host lethality.Differential regulation of human papillomavirus type 8 by interferon regulatory factors 3 and 7Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus.LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1Epstein-Barr virus latent membrane protein 1 regulates the function of interferon regulatory factor 7 by inducing its sumoylation.An auto-regulatory loop for EBV LMP2A involves activation of Notch.The pathological roles of BART miRNAs in nasopharyngeal carcinoma.Interferon regulatory factor 5 and autoimmune lupus.Nuclear factor-kappaB binds to the Epstein-Barr Virus LMP1 promoter and upregulates its expressionTumor Suppressor p53 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1.Epstein-Barr virus BRLF1 inhibits transcription of IRF3 and IRF7 and suppresses induction of interferon-beta.The p38 signaling pathway upregulates expression of the Epstein-Barr virus LMP1 oncogene.The LMP1 promoter can be transactivated directly by NF-kappaB.Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus.Colocalization of interferon regulatory factor 7 (IRF7) with latent membrane protein 1 (LMP1) of Epstein-Barr virus.Autoactivation of the Epstein-Barr virus oncogenic protein LMP1 during type II latency through opposite roles of the NF-kappaB and JNK signaling pathways.Human interferon regulatory factor 5 homologous epitopes of Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis induce a specific humoral and cellular immune response in multiple sclerosis patients.Four Promoters of IRF5 Respond Distinctly to Stimuli and are Affected by Autoimmune-Risk PolymorphismsInterferon regulatory factor 8 regulates caspase-1 expression to facilitate Epstein-Barr virus reactivation in response to B cell receptor stimulation and chemical induction.DNA Tumor Virus Regulation of Host DNA Methylation and Its Implications for Immune Evasion and Oncogenesis.Epstein-Barr and other viral mimicry of autoantigens, myelin and vitamin D-related proteins and of EIF2B, the cause of vanishing white matter disease: massive mimicry of multiple sclerosis relevant proteins by the Synechococcus phage.
P2860
Q24299740-1D035EEE-1F3E-45CA-B10B-6002544EAC96Q24306662-206983D8-8B72-49A2-B808-9EA10D6B5650Q24625246-A06B86E9-88B8-49F9-8989-86743521E35CQ33908810-2C310D67-F131-4D15-8223-242B9F8F255CQ34082662-1FA74D83-AC0E-49E3-9F11-EF380E28D61BQ34457888-DC111F65-3742-42E9-919B-780D777FE211Q35542816-9EB78320-D48E-4277-B9B6-52B04664C6D1Q35861199-528EE1AD-B4F1-4A68-9BBB-D8E22175511DQ36363843-DFFE8192-71AE-4C0A-A792-305BD79E9B5DQ36528115-E13903DB-900C-4AF8-9DD8-4A606440C5DEQ37995110-B159186A-AB10-4ABA-90F1-1B9E72024A6EQ38123907-EA029FA1-C933-4C98-9DA5-65F8D3BF8836Q38358818-A14EB5EF-4448-4D61-ADDF-C0B64F922BCEQ38631755-D118635E-C6F9-4E6F-A496-18227A02F99BQ39716669-2AA7F1B5-780F-4525-86BD-9A6D90623BEFQ39755299-C077EBE5-77A7-411D-8D81-220C3F394C98Q39874197-671BFD77-3CC6-4C59-9272-F85450BF08A9Q40112081-AE1342A9-9A93-423C-A49B-5AD9FB9BF479Q40266843-F03F2AC4-F1A1-41CB-9197-4B416F18ED80Q41995310-57FF638D-5F75-42E7-B290-0625F5F322D3Q42181574-6BADE5AA-367E-4916-9CDE-DE2A65D4EF29Q42716198-DA237BAF-5C66-4A16-9A43-AD41C5C5B0EAQ47550358-93FC9201-8613-4BBE-B022-F4B4ED4F2DE1Q50042001-0E1A1445-359A-4240-83D5-17372F73887DQ50066373-04C758AE-A800-4327-A8C4-7EB5A7896608
P2860
Interferon regulatory factor 5 represses expression of the Epstein-Barr virus oncoprotein LMP1: braking of the IRF7/LMP1 regulatory circuit.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Interferon regulatory factor 5 ...... IRF7/LMP1 regulatory circuit.
@ast
Interferon regulatory factor 5 ...... IRF7/LMP1 regulatory circuit.
@en
type
label
Interferon regulatory factor 5 ...... IRF7/LMP1 regulatory circuit.
@ast
Interferon regulatory factor 5 ...... IRF7/LMP1 regulatory circuit.
@en
prefLabel
Interferon regulatory factor 5 ...... IRF7/LMP1 regulatory circuit.
@ast
Interferon regulatory factor 5 ...... IRF7/LMP1 regulatory circuit.
@en
P2860
P1433
P1476
Interferon regulatory factor 5 ...... e IRF7/LMP1 regulatory circuit
@en
P2093
Joseph S Pagano
Leslie E Huye
P2860
P304
11671-11676
P356
10.1128/JVI.79.18.11671-11676.2005
P407
P50
P577
2005-09-01T00:00:00Z